This is the most frequently reported effect and is inherent to GHRP-6's mechanism Mild water retention and peripheral edema, particularly during the first 2 to 4 weeks Transient flushing, warmth, or dizziness immediately post-injection Injection site reactions (redness, minor swelling) Less Common: Tingling or numbness in the extremities (hands and feet), related to GH-mediated fluid shifts Head rush or lightheadedness shortly after administration Drowsiness, particularly with evening doses Dose-Dependent (above saturation dose): Elevated cortisol via ACTH stimulation
It also flags that people taking certain diabetes or blood pressure medications may experience compounded side effects
It may be easier to wean off
enhance satiety and promote fat metabolism
Membrane-initiated estradiol signaling regulates the central nervous system
If you're planning pregnancy, FDA guidance recommends discontinuing semaglutide approximately 2 months before a planned pregnancy and tirzepatide about 1 month before conception due to potential fetal risks